A clinical trial to study the effects of two drugs ,Brihat gangadhar churna and Cologrit formulation in patients with Irritable bowel syndrome
Phase 2
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2023/10/058353
- Lead Sponsor
- Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Grahani with features of Irritable bowel syndrome as per rome IV criteria
Patients aged between 18-60 yrs.
Patients of either gender.
Patients willing to participate and giving informed consent.
Exclusion Criteria
Patients with a history of IBD , celiac disease , abdominal surgeries, ulcerative colitis.
Patients suffering from any other type of systemic disorder like hypothyroidism, uncontrolled DM and HTN, cardiac disease, renal dysfunction will be excluded.
Individuals with evidence of malignancy.
Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br/ ><br> <br/ ><br>1. Constipation or loose stool <br/ ><br>2. Stools with foul odour <br/ ><br>3. Pain in abdomen <br/ ><br>4. Heaviness in abdomen <br/ ><br>5. Abdominal distension <br/ ><br>6. Anorexia <br/ ><br>7. Lassitude <br/ ><br>8. Burning sensation <br/ ><br>9. Indigestion <br/ ><br>10. Improperly formed stools <br/ ><br> <br/ ><br>Timepoint: Time point : 0 days 30th day 60th day
- Secondary Outcome Measures
Name Time Method <br/ ><br>1. Bristol stool form scale <br/ ><br>2. IBS-QOL <br/ ><br>3. IBS- severity score <br/ ><br> <br/ ><br>Timepoint: Time point : 0 days 30th day 60th day